Hyperphosphatemia Contributes to Skeletal Muscle Atrophy in Mice.

Area of Science:

• Nephrology
• Muscle Physiology
• Biochemistry

Background:

• Chronic kidney disease (CKD) is linked to hyperphosphatemia, vascular calcification, and skeletal muscle atrophy.
• Elevated phosphate damages vascular cells and promotes calcification.

Purpose of the Study:

• To investigate if high phosphate affects skeletal muscle cells.
• To determine if hyperphosphatemia, with or without CKD, is associated with skeletal muscle atrophy.

Main Methods:

• Used mouse models of CKD with hyperphosphatemia (adenine diet, Col4a3 knockout).
• Used mouse models of hyperphosphatemia without CKD (high-phosphate diet, klotho deficiency).
• Cultured primary mouse myotubes in high phosphate concentrations.

Main Results:

• Adenine, Col4a3-/-, and kl/kl mice exhibited reduced muscle mass, function, and atrophy.
• Mice on a high-phosphate diet for six months showed reduced muscle mass and function but not significant atrophy.
• In vitro studies demonstrated high phosphate induces atrophy in cultured myotubes.

Conclusions:

• Hyperphosphatemia is sufficient to induce skeletal muscle atrophy in experimental models.
• Elevated phosphate levels may contribute to skeletal muscle injury in CKD patients.